Phillips Ormonde Fitzpatrick Company Profile

00:12 EST 13th December 2018 | BioPortfolio

Phillips Ormonde Fitzpatrick has been at the forefront of intellectual property law in Australia since its establishment in Melbourne, in 1888. Having evolved to employ more than 140 people, we have expanded to include offices in Sydney and Adelaide, and have the ability to act directly in New Zealand. The Phillips Ormonde Fitzpatrick group of businesses offers a broad spectrum of premium IP services.
Phillips Ormonde Fitzpatrick Patent and Trade Mark Attorneys includes a large number of highly experienced professionals, qualified in a diversity of technologies, who specialise in obtaining and enforcing patents, trade marks and designs throughout the world - in association with an extensive network of over 500 international associates.
Our affiliated law firm, Phillips Ormonde Fitzpatrick Lawyers, provides a range of legal services relevant to the procurement and enforcement of intellectual property. The firm provides advice in relation to IP litigation, licensing and contracts. It has a strong reputation in relation to patent litigation, where every lead lawyer handling a case has a degree in science, is a registered patent attorney, and is a lawyer that has practised in the patent field for many years.
IP Organisers Pty Ltd, our other affiliated company, provides intellectual property research and searching services, including patent and trade mark searches and watches. In addition, the company provides clients with IP portfolio audits, IP management and reporting services, and general commercialisation advice. IP Organisers also maintains IP Menu, a global guide to intellectual property resources on the Internet


Level 23, 367 Collins Street


Phone: 61 3 9614 1944
Fax: 61 3 9614 1867

News Articles [49 Associated News Articles listed on BioPortfolio]

Midatech Pharma's chief executive officer Dr Jim Phillips to step down at the end of May

Dr Phillips's successor as CEO will be COO Dr Craig Cook, who has more than 20 years of international experience in the pharmaceutical, biomedical and high technology sectors

Phillips-Medisize, InterSystems to develop third-generation connected health platform

The integration of InterSystems HealthShare offers an information-sharing and analytics platform foundation designed for connected drug delivery devices, bio sensors and regulated Mobile Medical Appli...

Milberg Tadler Phillips Grossman Announces Christian Siebott Has Joined the Firm

NEW YORK, Oct. 22, 2018 /PRNewswire/ -- Milberg Tadler Phillips Grossman LLP is pleased to announce that class action and complex litigation attorney Christian Siebott Read more...

Midatech Pharma 'consistently delivering on sales growth', says CEO Jim Phillips

Jim Phillips, chief executive of Midatech Pharma Plc (LON:MTPH; NASDAQ: MTP) talks Proactive through the firms full year results which chart a year of both operational and financial progress. The ...

Government of Victoria:The Hon Gordon Rich-Phillips, Technology Minister, .Developing the Australian BioTech sector

In this episode of PharmaTelevision News Review, filmed at AusBio 2012 in Melbourne, Australia, Fintan Walton talks to The Hon Gordon Rich-Phillips, Technology Minister at Victoria Government, Austral...

hVIVO PLC on track to be profitable in 2019 says CEO Phillips

Drug development services specialist hVIVO PLC (LON:HVO) should be making a profit by the end of 2019, according to chief executive Trevor Phillips. First half numbers showed good progress on sale...

Amryt Pharma's Dr Helen Phillips on 'remarkable' real-world Lojuxta study

Amryt Pharma PLC (LON:AMYT) currently has an exclusive licence to sell Lojuxta to adults in the EU and other territories including the Middle East, North Africa, Turkey and Israel. Dr Helen Philli...

Midatech Pharma Plc 'very excited' to take GNP technology into trials

Midatech Pharma (LON:MTPH Nasdaq:MTP) is to take its gold-plated nanoparticle technology forward into trials as a treatment for advanced liver cancer. Chief executive Jim Phillips tells Proactive:...

PubMed Articles [15 Associated PubMed Articles listed on BioPortfolio]

Skin cancer phototype: a new classification directly related to skin cancer and based on responses from 2,869 individuals.

Fitzpatrick phototype (FST) classification (based on ability to tan and tendency to burn) is widely used for evaluating skin cancer risk; however, it was not developed for that purpose and has been cr...

Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel.

Acne vulgaris (acne) is the most common skin disease in patients who have darker skin with most frequent sequelae of post inflammatory hyperpigmentation (PIH).

Retraction Note: Purified umbilical cord derived mesenchymal stem cell treatment in a case of systemic lupus erythematosus.

The Editor-in-Chief is retracting this article because the authors have not obtained consent to publish from the patient whose details are described in this case report. The article has been removed t...

Aging in skin of color: Disruption to elastic fiber organization is detrimental to skin's biomechanical function.

Skin aging is a complex process involving the additive effects of time-dependent intrinsic aging and changes elicited via skin's interaction with the environment. Maintaining optimal skin function is ...

Photodynamic therapy for rosacea in Chinese patients.

Rosacea is a common chronic cutaneous disorder which is characterized by flushing, erythema, papulopustules and telangiectasia. The pathogenesis of the disease is still unknown. A multifaceted approac...

Clinical Trials [24 Associated Clinical Trials listed on BioPortfolio]

The Influence of Skin Pigmentation on UVB Induced Vitamin D Increase

Skin pigmentation (melanin) absorbs ultra violet type B (UVB) radiation found in sunlight and is believed to be responsible for darker-skinned persons' generally low 25(OH)D status. This p...

Caregiver Study Dr. Phillips

This study will examine whether a performing arts class will improve the well-being of primary unpaid caregivers of people with dementia

Primary Upper Limb Deep Vein Thrombosis. Is First Rib Resection Necessary?

The purpose of the study is to compare outcome of patients with effort thrombosis who were treated operatively to those treated nonoperatively

Light, Exercise Intensity and Mood in Overweight

The purpose of this study is to determine if an exposure to light in the morning has a positive influence on self-chosen exercise intensity on a bicycle ergometer in overweight and obese p...

Phase 1 Study of HF-LED-RL in Fitzpatrick Skin Types I to III

The goal of this study is to establish the safety of high fluence LED-RL at fluence of 480 J/cm2 and 640 J/cm2 in healthy non-Hispanic, Caucasian subjects. The hypothesis is that high flue...

Companies [26 Associated Companies listed on BioPortfolio]

Phillips Ormonde Fitzpatrick

Phillips Ormonde Fitzpatrick has been at the forefront of intellectual property law in Australia since its establishment in Melbourne, in 1888. Having evolved to employ more than 140 people, we have e...

Chevron Phillips ChemicalCompany LLC

On July 1, 2000, Chevron Corporation and Phillips Petroleum Company, now ConocoPhillips, combined its worldwide petrochemical businesses, excluding Chevron’s oronite additives business, to form Chev...

Fitzpatrick, Cella, Harper & Scinto LLP

Fitzpatrick, Cella, Harper & Scinto (, founded in 1971, is a leading national intellectual property law firm of nearly 150 lawyers with offices in New Yor...

Phillips 66

Phillips 66 is a diversified energy manufacturing and logistics company. With a portfolio of Midstream, Chemicals, Refining, and Marketing and Specialties businesses, the company ...

Chevron Phillips Chemical Company LP

Chevron Phillips Chemical Company LP is an indirect wholly-owned subsidiary of Chevron Phillips Chemical Company LLC, one of the world’s top producers of olefins and polyolef...

More Information about "Phillips Ormonde Fitzpatrick" on BioPortfolio

We have published hundreds of Phillips Ormonde Fitzpatrick news stories on BioPortfolio along with dozens of Phillips Ormonde Fitzpatrick Clinical Trials and PubMed Articles about Phillips Ormonde Fitzpatrick for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Phillips Ormonde Fitzpatrick Companies in our database. You can also find out about relevant Phillips Ormonde Fitzpatrick Drugs and Medications on this site too.

Quick Search


Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Corporate Database Quicklinks

Searches Linking to this Company Record